Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells
M Sehested, D Simpson, T Skovsgaard, et al.
Biochimica Et Biophysica Acta
|
August 22, 1997
Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity
T Litman, T Zeuthen, T Skovsgaard, et al.
Biochimica Et Biophysica Acta
|
August 22, 1997
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity
T Litman, T Zeuthen, T Skovsgaard, et al.
European Journal of Cell Biology
|
December 1, 1988
Proopiomelanocortin producing cells of spleen: increase after transplantation with opioid-peptide producing Ehrlich ascites tumor cells
L I Larsson, P Blume-Jensen, T Skovsgaard, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology
|
November 1, 1987
Interaction among two subpopulations of Ehrlich ascites tumor in vivo: evidence of a contact mediated immune response
K Aabo, L L Vindeløv, T Skovsgaard, et al.
Clinical Chemistry
|
October 1, 1993
Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation
G Sölétormos, V Schiøler, D Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
M Ryberg, D Nielsen, K Osterlind, et al.
Clinical Chemistry
|
April 1, 1996
Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up
G Sölétormos, D Nielsen, V Schiøler, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 27, 1998
Challenging drug resistance in cancer therapy--review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997
G Lehne, E Elonen, M Baekelandt, et al.
Journal of the National Cancer Institute
|
January 1, 1987
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines
M Sehested, T Skovsgaard, B van Deurs, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells
M Sehested, D Simpson, T Skovsgaard, et al.
Biochimica Et Biophysica Acta
|
August 22, 1997
Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity
T Litman, T Zeuthen, T Skovsgaard, et al.
Biochimica Et Biophysica Acta
|
August 22, 1997
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity
T Litman, T Zeuthen, T Skovsgaard, et al.
European Journal of Cell Biology
|
December 1, 1988
Proopiomelanocortin producing cells of spleen: increase after transplantation with opioid-peptide producing Ehrlich ascites tumor cells
L I Larsson, P Blume-Jensen, T Skovsgaard, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology
|
November 1, 1987
Interaction among two subpopulations of Ehrlich ascites tumor in vivo: evidence of a contact mediated immune response
K Aabo, L L Vindeløv, T Skovsgaard, et al.
Clinical Chemistry
|
October 1, 1993
Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation
G Sölétormos, V Schiøler, D Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
M Ryberg, D Nielsen, K Osterlind, et al.
Clinical Chemistry
|
April 1, 1996
Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up
G Sölétormos, D Nielsen, V Schiøler, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 27, 1998
Challenging drug resistance in cancer therapy--review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997
G Lehne, E Elonen, M Baekelandt, et al.
Journal of the National Cancer Institute
|
January 1, 1987
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines
M Sehested, T Skovsgaard, B van Deurs, et al.
Page
of 8